about
The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrestThe antimicrobial peptide LL-37 alters human osteoblast Ca2+ handling and induces Ca2+-independent apoptosis.Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.Extracellular Uridine Triphosphate and Adenosine Triphosphate Attenuate Endothelial Inflammation through miR-22-Mediated ICAM-1 Inhibition.Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression.Inhibition of microRNA-125a promotes human endothelial cell proliferation and viability through an antiapoptotic mechanism.Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation.Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signalingCardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samplesAltered serum miRNA profiles during acute rejection after heart transplantation: potential for non-invasive allograft surveillanceAntisense regulation of atrial natriuretic peptide expressionFunctional Screening Identifies MicroRNA Regulators of Corin Activity and Atrial Natriuretic Peptide BiogenesisProfiling of the plasma proteome across different stages of human heart failureProteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
P50
Q33754641-EFAC624A-6A53-4712-9B56-ABEEAC9BD403Q34585119-3B9183CB-5A0E-45DE-9C0F-EC874E269469Q36688493-FCDE72BA-AB37-49CC-8DFF-99E15E7F4902Q38862437-93C0E3A2-B918-42B4-BC58-1D1B4ABB345DQ42773654-50E7F67F-5EF2-4739-BE51-CF456BE6869AQ50320388-66BC6FFA-0A08-4396-8237-A30DB9F8658EQ51758811-27A1E9DE-D5E2-457F-96CB-BBDED1F5B1F8Q82811571-AD0A5903-53A8-4658-9F3E-84D20ED5401BQ84435715-EE77FF20-8781-4FA6-A545-16ED589AA7D3Q86067262-E421FE0B-9C6B-4EF2-8E3F-92A2D478A87FQ90020718-670C72D2-6048-47FA-9787-DE087854A598Q90239145-EF1CD617-BCCB-453B-8E35-8BBEEDF32B49Q92162744-87CAA89E-5554-43C8-ADED-A0A3700181A6Q92919892-23181375-7BD6-4964-9073-0963F262C5AB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
O Gidlöf
@en
O Gidlöf
@nl
type
label
O Gidlöf
@en
O Gidlöf
@nl
prefLabel
O Gidlöf
@en
O Gidlöf
@nl
P31
P496
0000-0002-7402-3139